Unknown

Dataset Information

0

The Upregulation of Leucine-Rich Repeat Containing 1 Expression Activates Hepatic Stellate Cells and Promotes Liver Fibrosis by Stabilizing Phosphorylated Smad2/3.


ABSTRACT: Liver fibrosis poses a significant global health risk due to its association with hepatocellular carcinoma (HCC) and the lack of effective treatments. Thus, the need to discover additional novel therapeutic targets to attenuate liver diseases is urgent. Leucine-rich repeat containing 1 (LRRC1) reportedly promotes HCC development. Previously, we found that LRRC1 was significantly upregulated in rat fibrotic liver according to the transcriptome sequencing data. Herein, in the current work, we aimed to explore the role of LRRC1 in liver fibrosis and the underlying mechanisms involved. LRRC1 expression was positively correlated with liver fibrosis severity and significantly elevated in both human and murine fibrotic liver tissues. LRRC1 knockdown or overexpression inhibited or enhanced the proliferation, migration, and expression of fibrogenic genes in the human hepatic stellate cell line LX-2. More importantly, LRRC1 inhibition in vivo significantly alleviated CCl4-induced liver fibrosis by reducing collagen accumulation and hepatic stellate cells' (HSCs) activation in mice. Mechanistically, LRRC1 promoted HSC activation and liver fibrogenesis by preventing the ubiquitin-mediated degradation of phosphorylated mothers against decapentaplegic homolog (Smad) 2/3 (p-Smad2/3), thereby activating the TGF-β1/Smad pathway. Collectively, these results clarify a novel role for LRRC1 as a regulator of liver fibrosis and indicate that LRRC1 is a promising target for antifibrotic therapies.

SUBMITTER: Wang Y 

PROVIDER: S-EPMC10932271 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Upregulation of Leucine-Rich Repeat Containing 1 Expression Activates Hepatic Stellate Cells and Promotes Liver Fibrosis by Stabilizing Phosphorylated Smad2/3.

Wang Yake Y   Li Xiaolong X   Guan Xiaowen X   Song Zhe Z   Liu Huanfei H   Guan Zhenzhen Z   Wang Jianwei J   Zhu Lina L   Zhang Di D   Zhao Liang L   Xie Peitong P   Wei Xiaoyi X   Shang Ning N   Liu Ying Y   Jin Zhongzhen Z   Ji Zhili Z   Dai Guifu G  

International journal of molecular sciences 20240227 5


Liver fibrosis poses a significant global health risk due to its association with hepatocellular carcinoma (HCC) and the lack of effective treatments. Thus, the need to discover additional novel therapeutic targets to attenuate liver diseases is urgent. Leucine-rich repeat containing 1 (LRRC1) reportedly promotes HCC development. Previously, we found that LRRC1 was significantly upregulated in rat fibrotic liver according to the transcriptome sequencing data. Herein, in the current work, we aime  ...[more]

Similar Datasets

| S-EPMC2790318 | biostudies-literature
| S-EPMC5809816 | biostudies-literature
| S-EPMC3887977 | biostudies-literature
| S-EPMC7077357 | biostudies-literature
| S-EPMC11567593 | biostudies-literature
| S-EPMC10508695 | biostudies-literature
| S-EPMC10634995 | biostudies-literature
| S-EPMC3317652 | biostudies-literature
| S-EPMC2932791 | biostudies-literature
| S-EPMC4962636 | biostudies-literature